In this episode, David Kaplan, MD, MSc, and Tamar Taddei, MD, discuss which patients should be screened for hepatocellular carcinoma, current surveillance recommendations, barriers to implementation, emerging biomarkers in development, and unmet needs in hepatocellular carcinoma surveillance.

Presenters:

David E. Kaplan, MD, MSc
Associate Professor
Perelman School of Medicine
Chief, Hepatology Section
Division of Gastroenterology and Hepatology
University of Pennsylvania
Director of Hepatology
Corporal Michael J. Crescenz VA Medical Center
Philadelphia, Pennsylvania

Tamar Taddei, MD
Professor
Section of Digestive Diseases
Department of Internal Medicine
Yale School of Medicine
Chief, GI Section
VA Connecticut Healthcare System
West Haven, Connecticut

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

HCC Surveillance: Challenges and Opportunities